What is the equivalent dose of clonazepam (Klonopin) for a patient taking 2mg of alprazolam (Xanax) daily?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Benzodiazepine Dose Conversion: Alprazolam to Clonazepam

For a patient taking 2mg of alprazolam (Xanax) daily, the equivalent clonazepam (Klonopin) dose is approximately 1mg daily, based on the standard 2:1 potency ratio between these benzodiazepines. 1

Conversion Ratio and Dosing

  • The standard benzodiazepine equivalency ratio between alprazolam and clonazepam is 2:1, meaning 2mg of alprazolam equals roughly 1mg of clonazepam based on comparative potency studies. 1

  • For patients taking alprazolam 2mg three times daily (6mg total), the clonazepam equivalent would be approximately 3mg daily, typically divided as 1mg TID or 1.5mg BID. 1

  • The minimum effective daily dose of clonazepam for panic disorder is 1.0mg, with doses of 1.0-2.0mg offering the best balance of therapeutic benefit and tolerability. 2

Critical Pharmacokinetic Differences

  • Clonazepam has a significantly longer half-life (30-40 hours) compared to alprazolam (6-12 hours), which fundamentally changes dosing dynamics and allows for less frequent dosing with more continuous anxiety control. 1

  • The longer half-life means slower onset of withdrawal symptoms if a dose is missed and greater drug accumulation with repeated dosing. 1

  • Due to these pharmacokinetic differences, clonazepam typically requires only once or twice daily dosing, whereas alprazolam often requires three to four times daily administration. 1

Safety Warnings and Monitoring

  • Clonazepam carries significant risks including morning sedation and cognitive impairment, reported in up to 58% of patients in some studies. 1

  • Clonazepam use is associated with risk of falls and confusion, especially at doses ≥2mg, with potential for subdural hematoma. 1

  • Clonazepam may worsen sleep apnea, even at doses of 0.5-1.0mg. 1

  • Before initiating conversion, screen for sleep apnea, gait disorders, and liver disease, and perform baseline cognitive and motor coordination assessment. 1

  • Monitor regularly for excessive sedation, cognitive function, fall risk, and signs of respiratory depression if sleep apnea is present. 1

Conversion Protocol

  • Perform gradual cross-titration when switching between benzodiazepines, informed by the half-life and receptor profile of each medication. 3

  • Start clonazepam at the equivalent dose (1mg for 2mg alprazolam) while gradually tapering alprazolam over 1-2 weeks to minimize withdrawal symptoms and rebound anxiety.

  • CYP3A4 expression is the major determinant of clonazepam plasma concentrations, with low expressers requiring substantially lower doses (0.029 mg/kg) compared to normal expressers (0.058 mg/kg bodyweight). 4

Discontinuation Considerations

  • Discontinuation of clonazepam can be challenging, with patients typically unable to substantially reduce doses despite tapering attempts. 1

  • When discontinuing clonazepam after intermediate-term use, reduce the dosage by 0.25mg per week after reaching 1mg daily, preceded by 0.5mg reductions every 2 weeks at higher doses. 5

  • Withdrawal symptoms are mostly mild and include anxiety, tremor, nausea, insomnia, excessive sweating, tachycardia, headache, weakness, and muscle aches. 5

  • Same-night relapse can occur if clonazepam is missed, highlighting the importance of adherence during maintenance therapy. 1

References

Guideline

Benzodiazepine Dose Conversion: Alprazolam to Clonazepam

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Optimization of Clonazepam Therapy Adjusted to Patient's CYP3A Status and NAT2 Genotype.

The international journal of neuropsychopharmacology, 2016

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.